Societe Generale discloses Bodycote stake while Bodycote stock costs EUR 10.90

Published on 10/08/2026 at 13:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Societe Generale reported 5.22 percent interests on October 7, 2026. Bodycote stock costs EUR 10.90 on October 8, 2026 after EUR 10.80.

Isometrisches 3D-Diagramm einer Prozesskette mit Ofen, Härtebad, Kühlregalen und Prüfstation — Isometrische 3D-Darstellung einer Wärmebehandlungs-Prozesskette mit Ofen, Härtebad und Prüfstation für Bodycote plc, ISIN GB00B3FLWH99, Illustration mit AI erstellt.

Bodycote stock was at EUR 10.90 at Lang & Schwarz on October 8, 2026 at 1:44 p.m. CEST, plus 0.93 percent versus the prior close of EUR 10.80. Societe Generale disclosed interests totaling 5.22 percent and short positions of 3.08 percent in Bodycote on October 7, 2026, according to TradingView.

Three events shape the takeover

On June 30, 2026, Bodycote reported first-half revenue of GBP 381.2 million, up from GBP 369.0 million, while net income rose to GBP 31.0 million from GBP 27.7 million, according to Simply Wall St.

On September 1, 2026, Bodycote agreed to Veritas Capital's recommended cash acquisition at GBp 940.00 per share, valuing the equity at GBP 1.65 billion. On September 28, 2026, the scheme document set out the voting process and the conditions for completion, as reported in the Financial Times.

On October 7, 2026, Societe Generale's disclosure showed 8,879,990 relevant securities representing 5.22 percent interests, alongside short positions representing 3.08 percent. The filing adds a new ownership datapoint to a transaction already centered on shareholder approval.

What does the vote require?

The scheme requires approval by a majority in number of participating shareholders representing at least 75.00 percent by value of the shares voted at the Court Meeting. The General Meeting must also approve the special resolution, followed by court sanction, according to the Financial Times.

The offer price comprises GBp 932.80 in cash and the FY26 interim dividend of GBp 7.20 per share. That structure matters because the headline GBp 940.00 consideration is not entirely cash, while the disclosed short position of 3.08 percent highlights a measurable counter-factor around the vote and completion timetable.

Dates set the next valuation test

Proxy instructions are due by October 19, 2026, while the Court Meeting is scheduled for October 21, 2026 at 10:00 a.m. London time and the General Meeting at 10:15 a.m. The transaction is expected to become effective in the first quarter of 2027, subject to shareholder, court and other conditions, according to the Financial Times.

Stock stays below the offer value

The EUR 10.90 Lang & Schwarz quote was intraday at 1:44 p.m. CEST on October 8, 2026, up 0.93 percent from the EUR 10.80 prior close dated October 7, 2026. Bodycote's LSE listing is quoted in GBp, so the GBp 940.00 offer and the euro market indication describe different trading venues and currencies.

The further course of trading is shown by the continuously updated real-time quote of Bodycote stock.